Skip to content

Study and compare the effect of Intralesional Radiofrequency and carbon dioxide Laser in Keloid and hypertrophic Scar

A comparative study of effectiveness of Intralesional Radiofrequency and ultra pulse carbondioxide laser ablation in keloid & hypertrophic scar

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020883
Enrollment
60
Registered
2019-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L910- Hypertrophic scar

Interventions

Intervention1: Intralesional Radiofrequency ablation: The device used-RF generator. Mode - cut/ coagulation Max. power output of 10 W. Intracath no 22 will be used with the insulation and small nick

Sponsors

Department of dermatology Government Medical College Bhavnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Keloid and hypertrophic scar Progressive or Stationary lesion Size No previous treatment in last 6 weeks

Exclusion criteria

Exclusion criteria: Pedunculated lesion Sensitivity to local anesthetic Pregnant females Infected or secondary changes on surface (e.g. excoriation/ eczema) Person with Pacemaker Person with unstable general condition Patient not willing for consent and follow up Patient in need of alternative treatment during the treatment course

Design outcomes

Primary

MeasureTime frame
Excellent response (90 %- almost complete flattening) Good response (71-90 % Significant flattening) Moderate response (51-70 % Adequate flattening) Poor response (=50 % Inadequate flattening) Timepoint: 28 weeks

Secondary

MeasureTime frame
Size Height The Vancouver Scar ScaleTimepoint: 0 week 16 weeks 28 weeks

Countries

India

Contacts

Public ContactDr Nancy Raiyani

government medical college and Sir T Hospital Bhavnagar Gujarat

hitamehta88@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026